Places xylazine, a substance used in veterinary care, on Schedule III of the Controlled Substances Act and limits who may lawfully possess it.

• Adds xylazine to Schedule III of the Controlled Substances Act and defines the term xylazine.
• Limits lawful possession of xylazine to people who obtained it from a registered veterinarian or a pharmacy filling a veterinarian's prescription, for animals in their care, animal-control programs, or wildlife programs.
• Delays the labeling, packaging, and distribution requirements for xylazine until one year after enactment, and the practitioner registration, inventory, and recordkeeping requirements until 60 days after enactment.
• Adds xylazine to DEA's ARCOS tracking system, directs the Sentencing Commission to review penalties for xylazine offenses, and requires DEA reports to Congress within 18 months and 4 years.

• Judiciary Committee (House)
• Energy and Commerce Committee (House)
• Health Subcommittee

Crime and Law Enforcement